[{"NetIncomeLoss_1_Q1_USD":-340955000.0,"OtherCommitmentDueInThirdYear_0_Q1_USD":1500000.0,"IncomeTaxesPaid_1_Q1_USD":103000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":11958000.0,"InterestPaidNet_1_Q1_USD":912000.0,"InventoryFinishedGoodsNetOfReserves_0_Q1_USD":21084000.0,"GainLossOnSaleOfPropertyPlantEquipment_1_Q1_USD":-82000.0,"CommitmentsAndContingencies_0_Q1_USD":null,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0_Q1_USD":9625000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":169489223.0,"TravelAndEntertainmentExpense_1_Q1_USD":66000.0,"GeneralAndAdministrativeExpense_1_Q1_USD":25587000.0,"DepreciationAndAmortization_1_Q1_USD":3498000.0,"IndefiniteLivedIntangibleAssetsExcludingGoodwill_0_Q1_USD":57333000.0,"ProvisionForDoubtfulAccounts_1_Q1_USD":805000.0,"OperatingLeaseLiability_0_Q1_USD":14927000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-69000.0,"EquityMethodInvestments_0_Q1_USD":8100000.0,"PurchaseObligation_0_Q1_USD":17359000.0,"OtherInvestments_0_Q1_USD":12083000.0,"OtherCommitmentDueInFourthYear_0_Q1_USD":1500000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":14243733.0,"AccountsReceivableGrossCurrent_0_Q1_USD":30298000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_1_Q1_USD":-2500000.0,"SellingAndMarketingExpense_1_Q1_USD":9739000.0,"FinanceLeaseLiabilityPaymentsDueYearTwo_0_Q1_USD":12438000.0,"CostOfGoodsAndServicesSold_1_Q1_USD":34518000.0,"ContractWithCustomerLiability_0_Q1_USD":0.0,"DepositsAssetsCurrent_0_Q1_USD":9285000.0,"AssetsCurrent_0_Q1_USD":571969000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q1_USD":2758000.0,"GoodwillForeignCurrencyTranslationGainLoss_1_Q1_USD":2164000.0,"InterestIncomeExpenseNonoperatingNet_1_Q1_USD":-6916000.0,"FinanceLeaseInterestPaymentOnLiability_1_Q1_USD":264000.0,"OtherCommitmentDueInSecondYear_0_Q1_USD":293249000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q1_USD":156030000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q1_USD":3351000.0,"OtherGeneralAndAdministrativeExpense_1_Q1_USD":7613000.0,"Liabilities_0_Q1_USD":627613000.0,"InterestPayableCurrent_0_Q1_USD":1158000.0,"NumberOfReportableSegments_1_Q1_Segment":2.0,"ProceedsFromSaleOfOtherInvestments_1_Q1_USD":2719000.0,"RepaymentsOfSeniorDebt_1_Q1_USD":1309000.0,"AccountsReceivableNetCurrent_0_Q1_USD":28304000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":1516000.0,"PrepaidExpenseCurrent_0_Q1_USD":5117000.0,"EquitySecuritiesFvNiUnrealizedGainLoss_1_Q1_USD":300000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1_Q1_USD":5664000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_0_Q1_USD":9868000.0,"InterestPayableCurrentAndNoncurrent_0_Q1_USD":413000.0,"SalariesWagesAndOfficersCompensation_1_Q1_USD":7013000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q1_USD":24035000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q1_USD":21075000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":1202000.0,"DepreciationDepletionAndAmortization_1_Q1_USD":4908000.0,"FinanceLeaseLiability_0_Q1_USD":15594000.0,"IntangibleAssetsGrossExcludingGoodwill_0_Q1_USD":210256000.0,"ForeignCurrencyTransactionGainLossBeforeTax_1_Q1_USD":699000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":416370000.0,"OtherAssetsNoncurrent_0_Q1_USD":5542000.0,"AmortizationOfIntangibleAssets_1_Q1_USD":2271000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-337202000.0,"FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q1_USD":6165000.0,"AccruedLiabilitiesAndOtherLiabilities_0_Q1_USD":60461000.0,"IncreaseDecreaseInInventories_1_Q1_USD":4893000.0,"FairValueAdjustmentOfWarrants_1_Q1_USD":263201000.0,"ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_0_Q1_shares":6209000.0,"FinanceLeaseLiabilityPaymentsDue_0_Q1_USD":19496000.0,"OtherCommitmentDueInNextTwelveMonths_0_Q1_USD":67897000.0,"OtherCommitmentsFutureMinimumPaymentsRemainderOfFiscalYear_0_Q1_USD":22200000.0,"ImpairmentOfInvestments_1_Q1_USD":0.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":234081000.0,"ForeignCurrencyTransactionGainLossUnrealized_1_Q1_USD":699000.0,"DebtInstrumentBasisSpreadOnVariableRate1_1_Q1_pure":0.0805,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q1_USD":2861000.0,"FinanceLeaseLiabilityUndiscountedExcessAmount_0_Q1_USD":3902000.0,"FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q1_USD":893000.0,"ProceedsFromWarrantExercises_1_Q1_USD":76106000.0,"InventoryRawMaterialsNetOfReserves_0_Q1_USD":15263000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-13008000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q1_USD":3753000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":7141000.0,"ProceedsFromSaleOfPropertyPlantAndEquipment_1_Q1_USD":171000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q1_USD":-341212000.0,"Goodwill_0_Q1_USD":169079000.0,"LongTermDebtPercentageBearingFixedInterestRate_0_Q1_pure":0.05,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q1_USD":3753000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q1_USD":30587000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0_Q1_USD":9619000.0,"IncomeLossFromEquityMethodInvestments_1_Q1_USD":-1787000.0,"PaymentsToAcquireEquityMethodInvestments_1_Q1_USD":493000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0_Q1_USD":9589000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q1_USD":3498000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":1000000.0,"LiabilitiesCurrent_0_Q1_USD":283989000.0,"OtherCommitment_0_Q1_USD":386346000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":197771000.0,"DeferredIncomeTaxLiabilitiesNet_0_Q1_USD":49293000.0,"ConvertibleSubordinatedDebtNoncurrent_0_Q1_USD":259443000.0,"LinesOfCreditCurrent_0_Q1_USD":49547000.0,"OperatingLeasePayments_1_Q1_USD":994000.0,"NumberOfOperatingSegments_1_Q1_Segment":2.0,"FiniteLivedIntangibleAssetsNet_0_Q1_USD":128889000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q1_USD":3746000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q1_USD":416370000.0,"AdditionalPaidInCapital_0_Q1_USD":1599713000.0,"GrossProfit_1_Q1_USD":13503000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q1_USD":186222000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":27171000.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":6117000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":30751000.0,"AccountsPayableCurrent_0_Q1_USD":48289000.0,"GainLossOnDerivativeInstrumentsNetPretax_1_Q1_USD":134000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":226668000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-1071058000.0,"IncomeTaxesReceivable_0_Q1_USD":16349000.0,"InventoryNet_0_Q1_USD":96544000.0,"AllowanceForDoubtfulAccountsReceivable_0_Q1_USD":1267000.0,"OperatingIncomeLoss_1_Q1_USD":-73310000.0,"IncreaseDecreaseInAccountsPayableTrade_1_Q1_USD":30513000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":-2703000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q1_USD":2179000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q1_USD":3260000.0,"LitigationSettlementExpense_1_Q1_USD":45000000.0,"ProfessionalFees_1_Q1_USD":3577000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":17478000.0,"ShareBasedCompensation_1_Q1_USD":7193000.0,"GainLossOnSaleOfInvestments_1_Q1_USD":75000.0,"Assets_0_Q1_USD":1168244000.0,"InventoryWorkInProcessNetOfReserves_0_Q1_USD":60197000.0,"EquityMethodInvestmentsFairValueDisclosure_0_Q1_USD":633000.0,"CurrentIncomeTaxExpenseBenefit_1_Q1_USD":378000.0,"FiniteLivedIntangibleAssetsGross_0_Q1_USD":152923000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":1168244000.0,"ExciseAndSalesTaxes_1_Q1_USD":4646000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_1_Q1_USD":48021000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":2466000.0,"PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear_0_Q1_USD":17359000.0,"StockholdersEquity_0_Q1_USD":540631000.0,"AllowanceForDoubtfulAccountsReceivableWriteOffs_1_Q1_USD":439000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":4367000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-2.01,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1_Q1_USD":33000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_1_Q1_USD":20645000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0_Q1_USD":7684000.0,"PropertyPlantAndEquipmentGross_0_Q1_USD":228358000.0,"AmortizationOfDebtDiscountPremium_1_Q1_USD":1653000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":6493000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":9314000.0,"DeferredIncomeTaxExpenseBenefit_1_Q1_USD":-635000.0,"AccruedProfessionalFeesCurrent_0_Q1_USD":905000.0,"Ticker":"TLRY","CIK":"1731348","name":"TILRAY, INC.","OfficialName":"Tilray Brands Inc. Class 2 Common Stock ","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"2601094383.0","Country":"Canada","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210510"}]